GSK to introduce Fluarix for pediatric use.

Published: 2005-10-27 06:58:00

Updated: 2005-10-27 06:58:00

GSK decided to supply Fluarix 0.25ml for pediatric uses, a flu vaccine, especially for children of 6 months to less than 3 years old, starting from Oct. this year, 0.5ml dose of which had been supplied.

Fluarix 0.25ml will be supplied in a pre-filled syringe for a dose, administering 0.5ml on...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK